Aetiology and pathogenesis of psoriasis

The hereditary transmission of psoriasis is suggested by epidemiological data and familial association, but remains incompletely defined, not appearing to follow simple autosomal dominant or recessive patterns. The confusion may be due to a multifactorial inheritance, or to inheritance of only a ‘predisposition’ to disease which requires an environmental stimuli for expression. Recent advances in genetic mapping indicate genetic heterogeneity, and suggest that definition of psoriasis at the level of the gene may soon be possible. Two of the three major pathogenic features of psoriasis—abnormal keratinocyte differentiation and hyperproliferation of keratinocytes—are secondary to altered growth and maturation kinetics related to the normal wound healing process. The third major pathogenic feature—infiltration of inflammatory components into the skin—can be explained by keratinocyte release of a wide variety of cytokines, immune and inflammatory modulators. Three theories have been proposed for the relationship between epidermal keratinocyte and immunocyte activation. The first theory proposes direct activation of epidermal keratinocytes by physical, chemical, or ultraviolet injury, increasing the synthesis and release of cytokines. which trigger T‐lymphocyte activation in an antigen‐independent fashion. The other two theories propose persistent T‐lymphocyte stimulation as a result of either antigen/superantigen presentation by antigen‐presenting cells, or as a result of autoreactivity. One or more of these mechanisms may he operative in different patients, at different times, or in response to different environmental stimuli. Also, the genetic heterogeneity of psoriasis suggests that different mechanisms could be linked to different genetic loci. Advances in understanding the aetiology and pathogenesis of psoriasis suggest the possibility of innovative, targeted therapies.

[1]  E. Christophers,et al.  Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. , 1985, Journal of the American Academy of Dermatology.

[2]  J. Weissenbach,et al.  Confirmation of genetic heterogeneity in familial psoriasis. , 1995, Journal of medical genetics.

[3]  R. S. Rogers Genetics of psoriasis. , 1975, Minnesota medicine.

[4]  M. Goodfield,et al.  The effect of oral indomethacin on psoriasis treated with the Ingram regime , 1991, The British journal of dermatology.

[5]  R. Trembath,et al.  An association between psoriasis and hereditary multiple exostoses. A clue for the mapping of a psoriasis susceptibility gene? , 1994, The British journal of dermatology.

[6]  G. Lazarus,et al.  Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. An important clue. , 1979, Archives of dermatology.

[7]  A. Bowcock Genetic locus for psoriasis identified. , 1995, Annals medicus.

[8]  E. Farber,et al.  The natural history of psoriasis in 5,600 patients. , 1974, Dermatologica.

[9]  A. Kawada,et al.  EXACERBATION OF PSORIASIS INDUCED BY INDOMETHACIN , 1981, The Journal of dermatology.

[10]  S. Breathnach,et al.  Psoriasis: Immune Indicators and Treatment , 1994 .

[11]  H. Baker THE INFLUENCE OF CHLOROQUINE AND RELATED DRUGS ON PSORIASIS AND KERATODERMA BLENORRHAGICUM. , 1966 .

[12]  A. Bowcock,et al.  Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. , 1994, Science.

[13]  A. Gottlieb,et al.  HLA region genes and immune activation in the pathogenesis of psoriasis. , 1990, Archives of dermatology.

[14]  G. Krueger,et al.  Epidemiology of psoriasis: clinical issues. , 1994, The Journal of investigative dermatology.

[15]  K. Krishna Koebner response in psoriasis. , 1998, Indian journal of dermatology, venereology and leprology.

[16]  S. Kantor Stress and psoriasis. , 1990, Cutis.